LAX-LYTE WITH FLAVOR PACKS
Post-LOEpolyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride
ANDAORALFOR SOLUTION
Approved
Feb 2010
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
LAX-LYTE WITH FLAVOR PACKS (polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride) by Design Pharmaceuticals is 3350 which causes water to be retained in the colon and produces a watery stool. First approved in 2010.
Drug data last refreshed 23h ago
Mechanism of Action
3350 which causes water to be retained in the colon and produces a watery stool.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on LAX-LYTE WITH FLAVOR PACKS at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.